The PDE-Glo™ Phosphodiesterase Assay is a luminescent, high-throughput screening (HTS) method for measuring cyclic nucleotide phosphodiesterase activity from purified sources. Cyclic nucleotide phosphodiesterases (PDEs) are involved in a myriad of cellular processes due to their ability to hydrolyze, and thus control, the levels of the second-messenger signaling molecules cAMP and cGMP.
The availability of selective inhibitors for PDEs has facilitated their use as tools to study cyclic nucleotide signaling and paved the way to investigate the role of PDEs in cellular and tissue pathologies. The PDE-Glo™ Phosphodiesterase Assay allows lead candidates to be identified from compound libraries. The assay is designed for 384-well plates, but assay volumes can easily be scaled for 96- or 1536-well plates. The PDE-Glo™ Phosphodiesterase Assay is optimized to work with both cAMP- and cGMP-dependent phosphodiesterases. The total time required for the assay from start to finish is less than 1 hour after the PDE reaction is complete.
Features - Benefits
Versatile: Works with both cAMP and cGMP PDEs. Sensitive:
Excellent signal:background ratios.
Scalable to 1536-well plate formats. Fast and Easy to Use:
Assay can be completed in <1 hour.
Homogeneous. Proven Luminescent Technology:
Powered by Ultra-Glo™ Luciferase.
Non-radioactive. No Interference by Fluorescent Compounds.
Applications
High-throughput analysis of library compounds to identify inhibitors of either cAMP- or cGMP-specific PDEs.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
